Friday, January 03, 2014 10:09:24 PM
Nice MOMO run and going strong with compelling storyline- watch-list!
Idera Pharmaceuticals Presents a Promising Opportunity
http://wallstcheatsheet.com/stocks/idera-pharmaceuticals-presents-a-promising-opportunity.html/?ref=YF
http://finance.yahoo.com/news/idera-pharmaceuticals-opens-enrollment-phase-123000547.html
Idera previously announced that it intends to submit a protocol to the FDA to conduct a Phase 1/2 trial in patients with diffuse large B-cell lymphoma (DLBCL) in the first quarter of 2014. DLBCL is an aggressive lymphoma. Approximately 30% of the patients with the activated B-cell-like, or ABC, sub-type are reported to also have MYD88 L265P mutation.
Form 4: Inside buys ( vote of confidence)
http://openinsider.com/search?q=idra
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
